BECN1 and leukemia: Previous studies have shown that BECN1‐mediated autophagy is associated with leukemia resistance to CTX [44]; lung cancer, embryonal carcinoma, cervical carcinoma resistance to DDP [45, 46, 47]; and cervical cancer resistance to VP16 [48].